Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs

Lignende værker

• A Phase 2, Double‐Blind, Placebo‐Controlled Trial to Investigate Potential Drug‐Drug Interactions Between Cannabidiol and Clobazam
  af: VanLandingham, Kevan E., et al.
  Udgivet: (2020)
• A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy
  af: Ben-Menachem, Elinor, et al.
  Udgivet: (2020)
• A Phase 1, Open‐Label, Pharmacokinetic Trial to Investigate Possible Drug‐Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
  af: Morrison, Gilmour, et al.
  Udgivet: (2019)
• Cannabidiol and Epilepsy: Sifting, Winnowing and Buzz
  af: Gidal, Barry E.
  Udgivet: (2016)
• A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
  af: Taylor, Lesley, et al.
  Udgivet: (2018)